GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

PDB ID UniProt ID Title ▼ Descriptor
A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES
INFLUENZA B/LEE/40 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH EPANA INHIBITOR (4-ACETAMIDO-2,4-DIDEOXY-D-GLYCERO-ALPHA-D-GALACTO-1-OCTOPYRANOSYL) PHOSPHONIC ACID
A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES
INFLUENZA A SUBTYPE N2 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH APANA INHIBITOR (4-ACETAMIDO-2,4-DIDEOXY-D-GLYCERO-BETA-D-GALACTO-1-OCTOPYRANOSYL) PHOSPHONIC ACID
A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES
INFLUENZA A SUBTYPE N2 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH EPANA INHIBITOR (4-ACETAMIDO-2,4-DIDEOXY-D-GLYCERO-ALPHA-D-GALACTO-1-OCTOPYRANOSYL) PHOSPHONIC ACID
A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES
INFLUENZA A SUBTYPE N9 NEURAMINIDASE (SIALIDASE) (E.C.3.2.1.18) COMPLEXED WITH EPANA INHIBITOR (4-ACETAMIDO-2,4-DIDEOXY-D-GLYCERO-ALPHA-D-GALACTO-1-OCTOPYRANOSYL) PHOSPHONIC ACID
A SARS-CoV-2 neutralizing antibody
A SARS-CoV-2 neutralizing antibody
A SARS-CoV-2 neutralizing antibody
A SARS-CoV-2 neutralizing antibody
A PRO TO GLY MUTATION IN THE HINGE OF THE ARABINOSE-BINDING PROTEIN ENHANCES BINDING AND ALTERS SPECIFICITY: SUGAR-BINDING AND CRYSTALLOGRAPHIC STUDIES
A PRO TO GLY MUTATION IN THE HINGE OF THE ARABINOSE-BINDING PROTEIN ENHANCES BINDING AND ALTERS SPECIFICITY: SUGAR-BINDING AND CRYSTALLOGRAPHIC STUDIES
Displaying entries 37561 - 37570 of 37922 in total

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01